9 months ago
BMRN
AnalystsMitchell S. KapoorMitchell S. Kapoor's Stock Forecasts
AnalystsMitchell S. Kapoor
Sectors:
Industries:
Analyst Ranking
Top 13%
#699 out of 5326 analysts
Average Return
+10.9%
Win Rate
49%60 out of 122
Risk vs Reward
Poor
Good
Mitchell S. Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oruka Therapeutics IncORKA | +507.87% | $15.25 | $92.70 | 2025-08-18 - 2026-07-17 | Buy |
Alumis IncALMS | +420.96% | $4.39 | $22.87 | 2025-08-14 - 2026-05-15 | Buy |
Oruka Therapeutics IncORKA | +234.66% | $27.70 | $92.70 | 2025-10-27 - 2026-07-17 | Buy |
Tyra Biosciences IncTYRA | +174.38% | $11.71 | $32.13 | 2025-08-22 - 2026-07-17 | Buy |
Boundless Bio IncBOLD | +123.42% | $1.11 | $2.48 | 2025-08-11 - 2026-07-17 | Buy |
Mitchell S. Kapoor Analyst Color
Get additional color on Mitchell S. Kapoor's coverage of popular stocks
10 months ago
BMRN
Mitchell S. Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ionis Pharmaceuticals IncIONS | 11 | Buy | $125.00 | +129.82% | Maintains | 11 days ago |
Meiragtx Holdings PLCMGTX | 2 | Buy | $20.00 | +60.77% | Reiterates | 13 days ago |
Crispr Therapeutics AgCRSP | 2 | Buy | $80.00 | +67.43% | Reiterates | 13 days ago |
Incyte CorpINCY | 11 | Buy | $140.00 | +19.40% | Reiterates | 22 days ago |
Oruka Therapeutics IncORKA | 6 | Buy | $120.00 | +29.45% | Reiterates | a month ago |
Intellia Therapeutics IncNTLA | 9 | Buy | $25.00 | +119.78% | Reiterates | a month ago |
Damora Therapeutics IncDMRA | 1 | Buy | $45.00 | +42.95% | Initiates Coverage On | a month ago |
Lyell Immunopharma IncLYEL | 4 | Buy | $45.00 | +237.84% | Reiterates | a month ago |
Neurogene IncNGNE | 5 | Buy | $70.00 | +87.62% | Reiterates | a month ago |
Kyverna Therapeutics IncKYTX | 5 | Buy | $25.00 | +235.57% | Reiterates | 2 months ago |
Legend Biotech CorpLEGN | 6 | Buy | $65.00 | +192.00% | Maintains | 2 months ago |
Evommune IncEVMN | 4 | Buy | $50.00 | +311.86% | Reiterates | 2 months ago |
Korro Bio IncKRRO | 3 | Buy | $15.00 | +22.45% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 7 | Hold | $50.00 | -16.09% | Maintains | 2 months ago |
Alumis IncALMS | 5 | Hold | $25.00 | -12.77% | Downgrades | 2 months ago |
Tyra Biosciences IncTYRA | 3 | Buy | $45.00 | +40.06% | Reiterates | 2 months ago |
Avalo Therapeutics IncAVTX | 4 | Buy | $35.00 | +80.69% | Maintains | 2 months ago |
Cartesian Therapeutics IncRNAC | 2 | Buy | $25.00 | +202.66% | Maintains | 2 months ago |
Cytomx Therapeutics IncCTMX | 3 | Buy | $11.00 | +203.87% | Maintains | 2 months ago |
Generate Biomedicines IncGENB | 2 | Buy | $25.00 | +84.37% | Maintains | 2 months ago |
Summit Therapeutics IncSMMT | 9 | Buy | $23.00 | +66.55% | Maintains | 3 months ago |
Halozyme Therapeutics IncHALO | 6 | Buy | $95.00 | +22.09% | Maintains | 3 months ago |
Century Therapeutics IncIPSC | 1 | Buy | $5.00 | +122.22% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 5 | Sell | $5.00 | -70.96% | Reiterates | 3 months ago |
Palisade Bio IncPALI | 1 | Buy | $7.00 | +255.33% | Initiates Coverage On | 4 months ago |
Crescent Biopharma IncCBIO | 3 | Buy | $22.00 | +49.15% | Maintains | 5 months ago |
Lexeo Therapeutics IncLXEO | 4 | Buy | $10.00 | +113.22% | Maintains | 6 months ago |
Instil Bio IncTIL | 3 | Buy | $125.00 | +1,584.64% | Reiterates | 10 months ago |
Editas Medicine IncEDIT | 2 | Buy | $5.00 | +67.79% | Reiterates | a year ago |
Metagenomi Therapeutics IncMGX | 1 | Buy | $7.00 | +464.52% | Reiterates | a year ago |
Zura Bio LtdZURA | 1 | Hold | $2.00 | -63.30% | Maintains | a year ago |
Boundless Bio IncBOLD | 1 | Buy | $4.00 | +61.29% | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.